Cargando…

AVIVA: a telehealth tool to improve cervical cancer screening in resource-constrained settings

Cervical cancer accounts for 21.7% of all cancer deaths in the sub-Saharan Africa with a case fatality rate of 68%. Nigeria’s Federal Ministry of Health has adopted cervical cancer screening (CCS) using visual inspection with acetic acid or Lugol’s iodine (VIA/VILI) and cryotherapy treatment for pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Ogunsola, Olabanjo Okunlola, Olawepo, John Olajide, Ajayi, Oluseye, Osayi, Emmanuel, Akinro, Yewande Toluwabori, Ifechelobi, Chukwuemeka, Chigbu, Chibuike, Okonkwo, Prosper, Ezeanolue, Echezona Edozie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10347443/
https://www.ncbi.nlm.nih.gov/pubmed/37433694
http://dx.doi.org/10.1136/bmjgh-2023-012311
_version_ 1785073549161005056
author Ogunsola, Olabanjo Okunlola
Olawepo, John Olajide
Ajayi, Oluseye
Osayi, Emmanuel
Akinro, Yewande Toluwabori
Ifechelobi, Chukwuemeka
Chigbu, Chibuike
Okonkwo, Prosper
Ezeanolue, Echezona Edozie
author_facet Ogunsola, Olabanjo Okunlola
Olawepo, John Olajide
Ajayi, Oluseye
Osayi, Emmanuel
Akinro, Yewande Toluwabori
Ifechelobi, Chukwuemeka
Chigbu, Chibuike
Okonkwo, Prosper
Ezeanolue, Echezona Edozie
author_sort Ogunsola, Olabanjo Okunlola
collection PubMed
description Cervical cancer accounts for 21.7% of all cancer deaths in the sub-Saharan Africa with a case fatality rate of 68%. Nigeria’s Federal Ministry of Health has adopted cervical cancer screening (CCS) using visual inspection with acetic acid or Lugol’s iodine (VIA/VILI) and cryotherapy treatment for precancerous lesions as the preferred screening and treatment strategy. Using the Exploration, Preparation, Implementation and Sustainment Framework, our study documents our experience during the development, piloting and roll-out of the APIN Public Health Initiatives (APIN)-developed VIA Visual Application (AVIVA) for CCS using the VIA method in 86 APIN-supported health facilities across 7 states in Nigeria. Between December 2019 and June 2022, with the aid of 9 gynaecologists and 133 case finders, a total of 29 262 women living with HIV received VIA-based CCS and 1609 of them were VIA-positive, corresponding to VIA positivity rate of 5.5%. Over the 30 months duration and the 5 phases of CCS scale-up, AVIVA development and expansion, a total of 1247 cases were shared via the AVIVA App (3741 pictures), with 1058 of such cases undergoing expert review, corresponding to a reviewer rate of 84.8%. Overall, the use of the AVIVA App improved both the VIA-positive and VIA-negative concordance rates by 16 percentage points each (26%–42% and 80%–96%, respectively) from baseline to the end of the study. We concluded that the AVIVA App is an innovative tool to improve CCS rates and diagnostic precision by connecting health facility staff and expert reviewers in resource-limited settings.
format Online
Article
Text
id pubmed-10347443
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-103474432023-07-15 AVIVA: a telehealth tool to improve cervical cancer screening in resource-constrained settings Ogunsola, Olabanjo Okunlola Olawepo, John Olajide Ajayi, Oluseye Osayi, Emmanuel Akinro, Yewande Toluwabori Ifechelobi, Chukwuemeka Chigbu, Chibuike Okonkwo, Prosper Ezeanolue, Echezona Edozie BMJ Glob Health Practice Cervical cancer accounts for 21.7% of all cancer deaths in the sub-Saharan Africa with a case fatality rate of 68%. Nigeria’s Federal Ministry of Health has adopted cervical cancer screening (CCS) using visual inspection with acetic acid or Lugol’s iodine (VIA/VILI) and cryotherapy treatment for precancerous lesions as the preferred screening and treatment strategy. Using the Exploration, Preparation, Implementation and Sustainment Framework, our study documents our experience during the development, piloting and roll-out of the APIN Public Health Initiatives (APIN)-developed VIA Visual Application (AVIVA) for CCS using the VIA method in 86 APIN-supported health facilities across 7 states in Nigeria. Between December 2019 and June 2022, with the aid of 9 gynaecologists and 133 case finders, a total of 29 262 women living with HIV received VIA-based CCS and 1609 of them were VIA-positive, corresponding to VIA positivity rate of 5.5%. Over the 30 months duration and the 5 phases of CCS scale-up, AVIVA development and expansion, a total of 1247 cases were shared via the AVIVA App (3741 pictures), with 1058 of such cases undergoing expert review, corresponding to a reviewer rate of 84.8%. Overall, the use of the AVIVA App improved both the VIA-positive and VIA-negative concordance rates by 16 percentage points each (26%–42% and 80%–96%, respectively) from baseline to the end of the study. We concluded that the AVIVA App is an innovative tool to improve CCS rates and diagnostic precision by connecting health facility staff and expert reviewers in resource-limited settings. BMJ Publishing Group 2023-07-11 /pmc/articles/PMC10347443/ /pubmed/37433694 http://dx.doi.org/10.1136/bmjgh-2023-012311 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Practice
Ogunsola, Olabanjo Okunlola
Olawepo, John Olajide
Ajayi, Oluseye
Osayi, Emmanuel
Akinro, Yewande Toluwabori
Ifechelobi, Chukwuemeka
Chigbu, Chibuike
Okonkwo, Prosper
Ezeanolue, Echezona Edozie
AVIVA: a telehealth tool to improve cervical cancer screening in resource-constrained settings
title AVIVA: a telehealth tool to improve cervical cancer screening in resource-constrained settings
title_full AVIVA: a telehealth tool to improve cervical cancer screening in resource-constrained settings
title_fullStr AVIVA: a telehealth tool to improve cervical cancer screening in resource-constrained settings
title_full_unstemmed AVIVA: a telehealth tool to improve cervical cancer screening in resource-constrained settings
title_short AVIVA: a telehealth tool to improve cervical cancer screening in resource-constrained settings
title_sort aviva: a telehealth tool to improve cervical cancer screening in resource-constrained settings
topic Practice
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10347443/
https://www.ncbi.nlm.nih.gov/pubmed/37433694
http://dx.doi.org/10.1136/bmjgh-2023-012311
work_keys_str_mv AT ogunsolaolabanjookunlola avivaatelehealthtooltoimprovecervicalcancerscreeninginresourceconstrainedsettings
AT olawepojohnolajide avivaatelehealthtooltoimprovecervicalcancerscreeninginresourceconstrainedsettings
AT ajayioluseye avivaatelehealthtooltoimprovecervicalcancerscreeninginresourceconstrainedsettings
AT osayiemmanuel avivaatelehealthtooltoimprovecervicalcancerscreeninginresourceconstrainedsettings
AT akinroyewandetoluwabori avivaatelehealthtooltoimprovecervicalcancerscreeninginresourceconstrainedsettings
AT ifechelobichukwuemeka avivaatelehealthtooltoimprovecervicalcancerscreeninginresourceconstrainedsettings
AT chigbuchibuike avivaatelehealthtooltoimprovecervicalcancerscreeninginresourceconstrainedsettings
AT okonkwoprosper avivaatelehealthtooltoimprovecervicalcancerscreeninginresourceconstrainedsettings
AT ezeanolueechezonaedozie avivaatelehealthtooltoimprovecervicalcancerscreeninginresourceconstrainedsettings